Related Experiment Video

Updated: Aug 21, 2026

Real-time Imaging of Myeloid Cells Dynamics in ApcMin/+ Intestinal Tumors by Spinning Disk Confocal Microscopy
05:21

Real-time Imaging of Myeloid Cells Dynamics in ApcMin/+ Intestinal Tumors by Spinning Disk Confocal Microscopy

Published on: October 6, 2014

Mutational activation of the RAS-RAF-MAPK and the Wnt pathway in small intestinal adenocarcinomas

H Bläker1, B Helmchen, A Bönisch

  • 1Institute of Pathology, University of Heidelberg, Germany. Hendrik_Blaeker@med.uni-heidelberg.de

Scandinavian Journal of Gastroenterology
|October 30, 2004
PubMed
Abstract

Insights

Small intestinal adenocarcinomas frequently activate the RAS-RAF-MAPK pathway via KRAS or BRAF mutations. Beta-catenin accumulation in the wnt pathway occurs in some cases, but not typically due to APC or CTNNB1 mutations, unlike colorectal cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gastroenterology

Background:

  • Small and large intestine adenocarcinomas share risk factors and morphology.
  • Despite similarities, these tumors appear to follow distinct genetic pathways.
  • This study investigates alternative pathway activation mechanisms in small intestinal carcinomas, comparing them to colorectal cancer.

Purpose of the Study:

  • To analyze alternative mechanisms of pathway activation in small intestinal carcinomas.
  • To investigate genetic alterations typically found in colorectal cancer within small intestinal tumors.
  • To understand the role of RAS-RAF-MAPK and wnt signaling pathways in small intestinal adenocarcinomas.

Main Methods:

  • Investigated 21 sporadic small intestinal carcinomas for mutations in KRAS, BRAF, CTNNB1, and APC.
  • Utilized immunohistochemical analysis for beta-catenin, a key component of wnt signaling.
  • Examined oncogene mutations and beta-catenin nuclear accumulation.

Main Results:

  • Oncogene mutations were detected in 62% of tumors (13/21).
  • KRAS mutations were found in 12 tumors; one novel BRAF mutation was observed.
  • Beta-catenin nuclear accumulation occurred in 5 carcinomas, linked to CTNNB1 mutation in one case, but not APC mutations.

Conclusions:

  • The RAS-RAF-MAPK pathway is frequently activated in small intestinal adenocarcinomas by KRAS or BRAF mutations.
  • Wnt pathway activation via beta-catenin accumulation plays a role in a subset of these tumors.
  • Unlike colorectal cancer, beta-catenin accumulation is generally not associated with APC or CTNNB1 mutations in small intestinal adenocarcinomas.

More Related Videos

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

In vitro Organoid Culture of Primary Mouse Colon Tumors07:33

In vitro Organoid Culture of Primary Mouse Colon Tumors

Published on: May 17, 2013

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...